CMOTEC B Share Price Performance
SEK 4.70
3.26 (226.39%)
Price SEK 4.70
Share Pricen/a
Scandinavian ChemoTech AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CMOTEC B Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Scandinavian ChemoTech AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 03, 2026
- -0.37
- 82.15%
- -74.49%
- 0%
About CMOTEC B
- Founded
- 2013
- Employees
- 1
- CEO
- WebsiteView website
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
